<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3AXanthine_oxidase_inhibitor%2F7%2Fen</id>
	<title>Translations:Xanthine oxidase inhibitor/7/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3AXanthine_oxidase_inhibitor%2F7%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Xanthine_oxidase_inhibitor/7/en&amp;action=history"/>
	<updated>2026-09-13T17:47:43Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Translations:Xanthine_oxidase_inhibitor/7/en&amp;diff=142910&amp;oldid=prev</id>
		<title>FuzzyBot: Importing a new version from external source</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Xanthine_oxidase_inhibitor/7/en&amp;diff=142910&amp;oldid=prev"/>
		<updated>2024-04-22T10:48:38Z</updated>

		<summary type="html">&lt;p&gt;Importing a new version from external source&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{| class=&amp;quot;wikitable sortable&amp;quot; style=&amp;quot;width:100%&amp;quot;&lt;br /&gt;
|+XO阻害剤&lt;br /&gt;
|-&lt;br /&gt;
!一般名&lt;br /&gt;
!先発名&lt;br /&gt;
!class=&amp;quot;unsortable&amp;quot;| 日本&lt;br /&gt;
!創薬/開発&lt;br /&gt;
!備考&lt;br /&gt;
|-&lt;br /&gt;
|[[allopurinol/ja]]&lt;br /&gt;
|[https://gskpro.com/ja-jp/products-info/zyloric/index/ ザイロリック](Zyloric) &lt;br /&gt;
([https://pins.japic.or.jp/pdf/newPINS/00048894.pdf PI]) ([https://gskpro.com/content/dam/global/hcpportal/ja_JP/products-info/zyloric/zyloric_tab-if.pdf IF])&lt;br /&gt;
|販売&lt;br /&gt;
|[[GSK plc]]&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|[[febuxostat/ja]]&lt;br /&gt;
|[https://medical.teijin-pharma.co.jp/product/iyaku/fe_fet.html フェブリク](Febric) ([https://pins.japic.or.jp/pdf/newPINS/00059341.pdf PI]) ([https://medical.teijin-pharma.co.jp/content/dam/teijin-medical-web/sites/documents/product/iyaku/fe_fet/fe_fet_if_2211.pdf IF])&lt;br /&gt;
|販売&lt;br /&gt;
|[[帝人ファーマ]]&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|[[topiroxostat/ja]]&lt;br /&gt;
|[https://med.skk-net.com/supplies/uriadec/ ウリアデック](Uriadec) &lt;br /&gt;
([https://med.skk-net.com/supplies/products/item/UDC2205.pdf PI]) ([https://med.skk-net.com/supplies/products/item/UDC_if_2211.pdf IF])&lt;br /&gt;
|販売&lt;br /&gt;
|[[三和化学研究所]]&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
A &amp;#039;&amp;#039;&amp;#039;xanthine oxidase inhibitor&amp;#039;&amp;#039;&amp;#039; is any substance that [[Enzyme inhibitor|inhibits]] the activity of [[xanthine oxidase]], an [[enzyme]] involved in [[purine metabolism]].  In [[human]]s, inhibition of xanthine oxidase reduces the production of [[uric acid]], and several [[medication]]s that inhibit xanthine oxidase are [[Indication (medicine)|indicated]] for treatment of [[hyperuricemia]] and related medical conditions including [[gout]]. Xanthine oxidase inhibitors are being investigated for management of [[reperfusion injury]].&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>